These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14561092)

  • 21. Relationship between exposure of (-)-N-{2-[(R)-3-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide (YM758), a "funny" if current channel inhibitor, and heart rate reduction in tachycardia-induced beagle dogs.
    Umehara K; Wada K; Noguchi K; Iwatsubo T; Usui T; Kamimura H
    Drug Metab Dispos; 2009 Jul; 37(7):1427-33. PubMed ID: 19359407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (1).
    Asano Y; Kitamura S; Ohra T; Aso K; Igata H; Tamura T; Kawamoto T; Tanaka T; Sogabe S; Matsumoto S; Yamaguchi M; Kimura H; Itoh F
    Bioorg Med Chem; 2008 Apr; 16(8):4715-32. PubMed ID: 18313304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and alpha-adrenolytic activity.
    Kulig K; Sapa J; Nowaczyk A; Filipek B; Malawska B
    Eur J Med Chem; 2009 Oct; 44(10):3994-4003. PubMed ID: 19447527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and synthesis of tetrahydroisoquinoline derivatives as potential multidrug resistance reversal agents in cancer.
    Li Y; Zhang HB; Huang WL; Li YM
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3652-5. PubMed ID: 18502125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and radioligand binding studies of C-5- and C-8-substituted 1-(3,4-dimethoxybenzyl)-2,2-dimethyl-1,2,3,4-tetrahydroisoquinoliniums as SK channel blockers related to N-methyl-laudanosine and N-methyl-noscapine.
    Graulich A; Scuvée-Moreau J; Seutin V; Liégeois JF
    J Med Chem; 2005 Jul; 48(15):4972-82. PubMed ID: 16033276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, pharmacological characterization, and quantitative structure-activity relationship analyses of 3,7,9,9-tetraalkylbispidines: derivatives with specific bradycardic activity.
    Schön U; Antel J; Brückner R; Messinger J; Franke R; Gruska A
    J Med Chem; 1998 Jan; 41(3):318-31. PubMed ID: 9464363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biological evaluation of 1,2,3,4-tetrahydroisoquinoline derivatives as potent and selective M2 muscarinic receptor antagonists.
    Watanabe T; Kinoyama I; Takizawa K; Hirano S; Shibanuma T
    Chem Pharm Bull (Tokyo); 1999 May; 47(5):672-7. PubMed ID: 10361700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo characterization of opioid activities of endomorphins analogs with novel constrained C-terminus: evidence for the important role of proper spatial disposition of the third aromatic ring.
    Yu Y; Shao X; Wang CL; Liu HM; Cui Y; Fan YZ; Liu J; Wang R
    Peptides; 2007 Apr; 28(4):859-70. PubMed ID: 17276550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxypropyl]-pyrrolidin-2-one derivatives with anti-arrhythmic, hypotensive, and alpha-adrenolytic activity.
    Kulig K; Sapa J; Maciag D; Filipek B; Malawska B
    Arch Pharm (Weinheim); 2007 Sep; 340(9):466-75. PubMed ID: 17806129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular hybridization, synthesis, and biological evaluation of novel chroman I(Kr) and I(Ks) dual blockers.
    Du L; Li M; Yang Q; Tang Y; You Q; Xia L
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1477-80. PubMed ID: 19185489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and evaluation of cis-3,4-disubstituted piperidines as potent CC chemokine receptor 2 (CCR2) antagonists.
    Cherney RJ; Nelson DJ; Lo YC; Yang G; Scherle PA; Jezak H; Solomon KA; Carter PH; Decicco CP
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5063-5. PubMed ID: 18722120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Agonist specific L-type Ca(2+)-current stimulation in ventricular myocytes by a novel steroid-like compound.
    Keller M; Pignier C; Santelli M; Vacher B; Niggli E; Egger M
    Cell Calcium; 2006 May; 39(5):425-33. PubMed ID: 16540165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and in vitro opioid receptor functional antagonism of analogues of the selective kappa opioid receptor antagonist (3R)-7-hydroxy-N-((1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic).
    Cai TB; Zou Z; Thomas JB; Brieaddy L; Navarro HA; Carroll FI
    J Med Chem; 2008 Mar; 51(6):1849-60. PubMed ID: 18307295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis and pharmacological screening of novel antihypertensive agents using hybrid approach.
    Bhandari SV; Bothara KG; Patil AA; Chitre TS; Sarkate AP; Gore ST; Dangre SC; Khachane CV
    Bioorg Med Chem; 2009 Jan; 17(1):390-400. PubMed ID: 19036593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and pharmacological evaluation of phenolic 2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinolin-4-ols as a new norepinephrine potentiator.
    Kihara M; Ikeuchi M; Kobayashi Y; Nagao Y; Hashizume M; Moritoki H
    Drug Des Discov; 1994 Apr; 11(3):175-83. PubMed ID: 7548633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tetrahydroisoquinolines as dopaminergic ligands: 1-Butyl-7-chloro-6-hydroxy-tetrahydroisoquinoline, a new compound with antidepressant-like activity in mice.
    Berenguer I; El Aouad N; Andujar S; Romero V; Suvire F; Freret T; Bermejo A; Ivorra MD; Enriz RD; Boulouard M; Cabedo N; Cortes D
    Bioorg Med Chem; 2009 Jul; 17(14):4968-80. PubMed ID: 19540762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potent and selective inhibitors of platelet-derived growth factor receptor phosphorylation. 3. Replacement of quinazoline moiety and improvement of metabolic polymorphism of 4-[4-(N-substituted (thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline derivatives.
    Matsuno K; Ushiki J; Seishi T; Ichimura M; Giese NA; Yu JC; Takahashi S; Oda S; Nomoto Y
    J Med Chem; 2003 Nov; 46(23):4910-25. PubMed ID: 14584942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives.
    Colabufo NA; Berardi F; Cantore M; Perrone MG; Contino M; Inglese C; Niso M; Perrone R; Azzariti A; Simone GM; Porcelli L; Paradiso A
    Bioorg Med Chem; 2008 Jan; 16(1):362-73. PubMed ID: 17936633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitors of phenylethanolamine N-methyltransferase and epinephrine biosynthesis. 3. Bis[tetrahydroisoquinoline]s.
    DeMarinis RM; Bryan WM; Hillegass LM; McDermott D; Pendleton RG
    J Med Chem; 1981 Jun; 24(6):756-9. PubMed ID: 7252985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The heart rate-lowering agent ivabradine inhibits the pacemaker current I(f) in human atrial myocytes.
    El Chemaly A; Magaud C; Patri S; Jayle C; Guinamard R; Bois P
    J Cardiovasc Electrophysiol; 2007 Nov; 18(11):1190-6. PubMed ID: 17850290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.